Dr Ian Geh's Published Studies

List of Publications

Moran B, Karandikar S, Geh I. Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017) - Introduction. Colorectal Dis 20 JUN 2017 | DOI: 10.1111/codi.13702. PMID: 28632314

Cunningham C, Leong K, Clark S, Plumb A, Taylor S, Geh I, Karandikar S, Moran B. Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the management of cancer of the colon, rectum and anus (2017) - diagnosis, investigations and screening. Colorectal Dis 20 JUN 2017 | DOI: 10.1111/codi.13703. PMID: 28632312

Moran B, Cunningham C, Singh T, Sagar P, Bradbury J, Geh I, Karandikar S. Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the management of cancer of the colon, rectum and anus (2017) - Surgical management. Colorectal Dis 20 JUN 2017 | DOI: 10.1111/codi.13704. PMID: 28632309

Gollins S, Moran B, Adams R, Cunningham C, Bach S, Sun Myint A, Renehan A, Karandikar S, Goh V, Prezzi D, Langman G, Ahmedzai S, Geh I. Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the management of cancer of the colon, rectum and anus (2017) - Multidisciplinary management. Colorectal Dis 20 JUN 2017 | DOI: 10.1111/codi.13705. PMID: 28632307

Geh I, Gollins S, Renehan A, Scholefield J, Goh V, Prezzi D, Moran B, Bower M, Alfa-Wali M, Adams R. Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the management of cancer of the colon, rectum and anus (2017) - Anal cancer. Colorectal Dis 20 JUN 2017 | DOI: 10.1111/codi.13709. PMID: 28632308

Pasquale S, Yim G, Zohra RS, Mocellin S, Nyanhongo D, Marriott P, Geh JI, Griffiths EA. Survival after neoadjuvant and adjuvant treatments compared to surgery alone for resectable oesophageal carcinoma: a network analysis. Ann Surg 2017; 265: 481-91. PMID: 27429017

Crosby T, Hurt CN, Falk S, Gollins S, Staffurth J, Ray R, Bridgewater JA, Geh JI, Cunningham D, Blazeby J, Roy R, Maughan T, Griffiths G, Mukherjee S. Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer. Brit J Cancer 2017;Mar 14;116(6):709-716. doi: 10.1038/bjc.2017.21. PMID: 28196063

Yahya S, Heyes G, Nightingale P, Lamin S, Chanda S, Geh I, Spooner D, Cruickshank G, Sanghera P. Linear accelerator radiosurgery for arteriovenous malformations: updated literature review. J Clin Neurosurg 2017; 38: 91-5. PMID: 28117260

Edwards N, Nolan O, Pawade T, Oelofse T, Singh H, Mehrzad H, Zia Z, Geh JI, Ayuk J, Palmer D, Shah T, Rooney S, Steeds R. Effect of valvular surgery in carcinoid heart disease: an observational cohort study. J Clin Endocrin Metabolic Med 2016; 101: 183-90. PMID: 26580239

Smart CJ, Korsgen S, Hill J, Speake D, Levy B, Steward M, Geh JI, Robinson J, Sebag-Montefiore D, Bach SP. A multicentre cohort study of organ preservation for T1 and T2 rectal cancer using short course preoperative radiotherapy and TEMS. Br J Surg 2016; Jul; 103(8): 1069-75. PMID: 27146472

Morris E, Finan PJ, Spencer K, Geh I, Crellin A, Quirke P, Thomas JD, Lawton S, Adams R, Sebag-Montefiore D. Wide variation in the use of radiotherapy in the management of surgically treated rectal cancer across the English NHS. Clin Oncol 2016 28(8); 522-31. PMID: 26936609

Rees J, Hurt C, Gollins S, Mukherjee S, Maughan T, Falk SJ, Staffurth J, Ray R, Bashir N, Bridgewater J, Geh JI, Cunningham D, Roy R, Griffiths G, Nixon L, Blazeby JM, Crosby T. Patient reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer. Brit J Cancer 2015: 113: 603-10. PMID: 26203761

Linear accelerator stereotactic radiosurgery for vestibular schwannomas: a UK series. Benghiat H, Heyes G, Nightingale P, Hartley A, Tiffany M, Spooner D, Geh JI, Cruickshank G, Irving R, Sanghera P. Clin Oncol 2014; 26: 309-15. PMID: 24636634

Glynne-Jones R, Kadalayil L, Meadows H, Cunningham D, Samuel L, Geh I, Lowdell C, James R, Beare S, Begum R, Sebag-Montefiore D, on behalf of the ACT II study group. Tumor-related and treatment-related colostomy-free survival (CFS) following chemoradiation (CRT) using mitomycin (MMC) or cisplatin (CisP), with or without maintenance 5FU/CisP chemotherapy (CT) in squamous cell carcinoma of the anus (SCCA): Results of ACT II. Ann Oncol 2014; 25: 1616-22. PMID: 24827136

Tiernan J, Cook A, Geh I, George B, Magill L, Northover J, Verjee A, Wheeler J, Fearnhead N. Use of modified Delphi approach to develop research priorities for the Association of Coloproctology of GB and Ireland. Colorectal Dis 2014; 16: 965-70. PMID: 25284641

Pettit L, Meade S, Sanghera P, Glaholm J, Geh JI, Hartley A. Can radiobiological parameters derived from squamous cell carcinoma of the head and neck be used to predict local control in anal cancer treated with chemoradiation? Br J Radiol 2013 Jan; 86 (1021). PMID: 23239699

Crosby T, Hurt C, Falk S, Gollins S, Mukherjee S, Staffurth J, Ray R, Bashir N, Bridgewater JA, Geh JI, Cunningham D, Blazeby J, Roy R, Maughan T, Griffiths G. A multicentre, phase II/III randomized trial of chemoradiotherapy in oesophageal caner plus or minus cetuximab - the SCOPE 1 trial. Lancet Oncology 2013; 14: 627-37. PMID: 23623280
.
Geh JI, Ma YT. Commentary: Evolution of systemic therapy for metastatic colorectal cancer. Colorectal Dis 2011; 13: 852-4. PMID: 21762349

Sinha V, Dyer P, Roy-Choudhury S, Geh JI, Karandikar S. A case of carcinoid crisis following a fine-needle biopsy of hepatic metastasis. Eur J Gastroenterol Hepatol 2009; 21: 101-3. PMID: 19086149

Harris AR, Bowley DM, Stannard A, Kurrimboccus S, Geh JI, Karandiakr S. Socioeconomic deprivation adversely affects survival for patients with rectal cancer. Br J Surg 2009; 96: 763-8. PMID: 19526619

Sanghera P, Wong DWY, McConkey CC, Geh JI, Hartley A. Chemoradiotherapy for rectal cancer: an updated analysis of factors affecting pathological response. Clin Oncol 2008; 20: 176-83. PMID: 18248971

Wong D, Lupton S, Zaman L, Peake D, Spooner D, Taniere P, Geh JI. Use of imatinib mesylate in gastrointestinal stromal tumours (GISTs): Pan-Birmingham Cancer Network experience. Clin Oncol 2008; 20: 517-22. PMID: 18514495

Henry AM, Ryder WDJ, Moore C, Sherlock DJ, Geh JI, Dunn P, Price P. Chemo-radiotherapy for locally advanced pancreatic cancer: a radiotherapy dose escalation and organ motion study.  Clin Oncol 2008; 20: 541-7. PMID: 18562186

Osman F, Geh JI, Griffith MJ. An unusual cause of cardiac paradox. Eur J Echocardiogr 2007; 8: 91-2. PMID: 16784896

Salmons N, Pallalau A, Gregg RJ, Woolhouse I, Tanière P, Geh JI. Lymphomatoid granulomatosis in a patient being treated for metastatic gastrointestinal stromal tumour with imatinib mesylate. J Clin Path 2007; 60: 199-201. PMID: 17264244

Geh JI, Bond SJ, Bentzen SM, Glynne-Jones R. Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: Evidence of a radiation and chemotherapy dose response. Radiother Oncol 2006; 78: 236-44. PMID: 16545878

Giridharan S, Vakkalanka B, Anwar MS, Geh JI, Glaholm J, Churn M, Adab F, Grieve R, McConkey C, Hartley A. Multicentre prospective audit of surgical outcomes and acute complications following short course preoperative radiotherapy for resectable rectal cancer. Colorectal Dis 2005; 7: 43-6. PMID: 15606583

Wilson D, Hiller L, Geh JI. Review of second-line chemotherapy for advanced gastric adenocarcinoma. Clin Oncol 2005; 17: 81-90. PMID: 15830569

Ayuk J, Natarajan G, Geh JI, Mitchell RD, Gittoes NJL. Pituitary carcinoma with a single metastasis causing cervical spinal cord compression. J Neurosurg 2005; 2: 349-52. PMID: 15796362

Hartley A, Ho KF, McConkey C, Geh JI. An analysis of factors associated with pathological complete response of rectal adenocarcinoma following chemoradiotherapy in phase II/III trials. Br J Radiol 2005; 78: 934-8. PMID: 16177017

Clark MA, Hartley A, Geh JI. Anal canal cancer. Lancet Oncology 2004; 5: 149-57. PMID: 15003197

Wilson D, Hiller L, Geh JI. ECF in stomach cancer. Clin Oncol 2004; 16: 381-2 (letter). PMID: 15341448

Hussain SA, Stocken DD, Riley P, Palmer DH, Peake D, Geh JI, Spooner D, James ND. A phase I/II study of gemcitabine and fractionated cisplatin in an out-patient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer. Br J Cancer 2004; 91: 844-9. PMID: 15292922

Hartley A, Giridharan S, Srihari N, McConkey C, Geh JI. Impaired postoperative neutrophil leucocytosis and acute complications following short course preoperative radiotherapy for operable rectal cancer. Eur J Surg Oncol 2003; 29: 155-157. PMID: 12633558

King M, Tolan S, Giridharan S, McConkey C, Hartley A, Geh JI. Late toxicity after short course preoperative radiotherapy and total mesorectal excision for resectable rectal cancer. Clin Oncol 2003; 15: 233-6. PMID: 12924451

Geh JI. The use of chemoradiotherapy in oesophageal cancer. Eur J Cancer 2002; 38: 300-313. PMID: 11803146

Hartley A, Giridharan S, Gray L, Billingham L, Ismail T, Geh JI. Retrospective study of acute toxicity following short-course preoperative radiotherapy. Br J Surg 2002; 89: 889-95. PMID: 12081739

Geh JI, Crellin AM, Glynne-Jones R. Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 2001; 88: 338-56. PMID: 11260097

Geh JI, Glynne-Jones R, Kwok QSK, Banerji U, Livingstone JI, Townsend ER, Harrison RA, Mitchell IC. Preoperative ECF chemotherapy for advanced gastro-oesophageal adenocarcinoma. Clin Oncol 2000; 12: 182-7. PMID: 10942336

Bygrave HA, Geh JI, Jani Y, Glynne-Jones R. Neurological complications of 5-fluorouracil chemotherapy: case report and review of the literature. Clin Oncol 1998; 10: 334-6. PMID: 9848338

Geh JI, Glynne-Jones R. Cervical spine metastases in colorectal carcinoma. Clin Oncol 1998; 10: 125-8. PMID: 9610902

Geh JI, Spittle MF. Oncological Problems in AIDS: a review of the clinical features and management. Ann Acad Med Singapore 1996; 25: 380-91. PMID: 8876905


Book Chapters

Khan Y, Radley S, Geh JI. Anal Cancer. In: Surgery of the anal canal. ECAB clinical update: Surgical Gastroenterology and liver transplantation. Ed: Karandikar S (2014).

Ford D, Geh JI. Oesophageal Cancers. In: Oxford Desk Reference: Oncology. Eds: Ajithkumar T, Cook N, Hatcher H, Barrett A. Oxford University Press, Oxford (2011).

Ford D, Walji N, Geh JI. Stomach Cancers. In: Oxford Desk Reference: Oncology. Eds: Ajithkumar T, Cook N, Hatcher H, Barrett A. Oxford University Press, Oxford (2011).

Chambers RJ, Geh I, Roy-Choudhury S. Oesophageal tumours. In: Radiotherapy in Practice: Imaging. Eds: Hoskin P, Goh V. Oxford University Press, Oxford (2010).

Miller B, Geh I, Roy-Choudhury S. Gastric tumours. In: Radiotherapy in Practice: Imaging. Eds: Hoskin P, Goh V. Oxford University Press, Oxford (2010).

Miller B, Geh I, Roy-Choudhury S. Hepatic and biliary tumours. In: Radiotherapy in Practice: Imaging. Eds: Hoskin P, Goh V. Oxford University Press, Oxford (2010).

Miller B, Geh I, Roy-Choudhury S. Pancreatic tumours. In: Radiotherapy in Practice: Imaging. Eds: Hoskin P, Goh V. Oxford University Press, Oxford  (2010).

Mahon B, Seddon B, Geh I. Gastrointestinal stromal tumours. In: Radiotherapy in Practice: Imaging. Eds: Hoskin P, Goh V. Oxford University Press, Oxford (2010).

Anwar MS, Geh JI, Spooner D. The role of radiotherapy in upper gastrointestinal tumours. In: Upper Gastrointestinal Surgery. Eds: Fielding JWL, Hallissey MT. Springer Specialist Surgical Series (2005).


National Guidelines

Association of Coloproctology of Great Britain & Ireland. Guidelines for the Management of Cancer of the Colon, Rectum and Anus (2017).
Chair of Guideline Development Committee

Reid R, Bulusu R, Carroll N, Eatock M, Geh I, Judson I, O’Dwyer P, Warren B, Seddon B, Hill G. Guidelines for the management of gastrointestinal stromal tumours (GIST) 2009.
Member of Guideline Development Committee

Association of Coloproctology of Great Britain & Ireland. Guidelines for the Management of Colorectal (3rd Edition) 2007.
Member of Guideline Development Committee

Royal College of Radiologists Radiotherapy Dose-Fractionation: Gastro-Oesophageal Cancer. June 2006 (ISBN 1-905034-14-8).
Member of Guideline Development Committee

Bulusu R, Eatock, Carrol, Geh I, Hardwick R, Judson I, Roberts A, Reid R, Toh, S, Warren B. Management of patients with gastrointestinal stromal tumours (GISTs) 2004.
Member of Guideline Development Committee


List of Invited Lectures and Oral Presentations

Introduction and audit data
Royal College of Radiologists, MDT Management of Anal Cancer, Birmingham 18 Oct 2017

Defunctioning stomas
Royal College of Radiologists, MDT Management of Anal Cancer, Birmingham 18 Oct 2017

Chemoradiotherapy for early rectal cancer
SPECC Workshop, Good Hope Hospital, Sutton Coldfield, 13 May 2016

Neoadjuvant chemotherapy in colon and rectal cancer
6th International Colorectal Masterclass, Pelican Centre, Basingstoke, 7 April 2016

Neoadjuvant therapy - tailored for different diseases?
St Mark’s Hospital, London, 25 November 2015

Update on rectal cancer
37th National Conference of Association of Colon & Rectal Surgeons of India, Lucknow, India, 27 September 2014

Rectal cancer MDT case presentations
37th National Conference of Association of Colon & Rectal Surgeons of India, Lucknow, India, 27 September 2014

Management of colorectal adenocarcinoma in the presence of synchronous liver metastases - an oncologist’s perspective
LSSCN HPB Educational Meeting, Royal Blackburn Hospital, 17 July 2013

Multidisciplinary management of colorectal cancers (preoperative radiotherapy)
Pelican Centre, Basingstoke, 26 January 2012

Whats new in rectal cancer? The apparent complete response
Dukes’ Club Annual Meeting, Kenilworth, 25th February 2012

Management of GISTs
Association of Surgeons of GB and Ireland, Liverpool, 11 May 2012

Pattern and treatment of locoregional failure after definitive chemoradiotherapy for anal cancer
Association of Coloproctology of GB & Ireland Annual Meeting, Dublin, 3 July 2012

Rectal cancer - Not for the chop (co-chair of session and case presentations)
Association of Coloproctology of GB & Ireland Annual Meeting, Dublin, 3 July 2012

Management of oesophageal cancer
Annual Scientific Congress of Malaysian Oncologoical Society, Melacca, 8 September 2012

Update on colorectal cancer
Annual Scientific Congress of Malaysian Oncologoical Society, Melacca, 8 September 2012

Neoadjuvant therapy for lower third rectal cancer
Association of Coloproctology of GB & Ireland Annual Meeting, Birmingham, 22 June 2011

The long and short of radiotherapy in rectal cancer
Asia Pacific Cancer Conference, Kuala Lumpur, Malaysia, 11 November 2011

Multidisciplinary management of rectal cancer
Asia Pacific Cancer Conference, Kuala Lumpur, Malaysia, 11 November 2011

Mutations in GISTs and their implications for treatment (GIST Support UK)
GIST Support UK, Birmingham, 26 April 2010

Multidisciplinary management of colorectal cancers: low rectal cancers
Case presentations
Controversies in the use of radiotherapy in low rectal cancers
Association of Coloproctology of GB & Ireland Annual Meeting, Bournemouth, 29 June 2010

Neoadjuvant radiotherapy and organ conservation in early rectal cancer
Association of Coloproctology of GB & Ireland Annual Meeting, Bournemouth, 30 June 2010

Chemoradiation trials in pancreatic cancer: PACER, SCALOP and PERU
NCRI Upper GI Trials Annual Meeting, London, 15 October 2009

Debate: Should we routinely use short course preoperative radiotherapy in rectal cancer?
UK Coloectal Cancer Consensus Meeting 2008, London, 18 November 2008

The role of radiotherapy and chemotherapy in rectal cancer
BIR President’s Conference 2007: Developments in the Diagnosis and Treatment of Colorectal and Breast Cancer, 18 May 2007

Controversies of preoperative chemoradiotherapy in oesophageal cancer
Combined Chemotherapy & Radiotherapy in GI Tumours, British Institute of Radiology, London, 16 November 2007

Evidence base for short course preoperative radiotherapy
Royal Society of Medicine (Coloproctology & Oncology Sections), London, 24 February 2006

Radiotherapy planning workshop (lower GI cancer): The bottom line of anal cancer planning
British Institute of Radiology, London, 31 March 2006

Multimodality treatment of esophageal cancer
International Symposium on Progress in Esophageal Diseases, Mainz, Germany, 24 June 2006

How do The CR 07 results fit with other recent trials?
Association of Coloproctology of GB & Ireland 2006 Annual Meeting, Gateshead, 4 July 2006

The NCRI SCOPE-1 trial
NCRI Upper GI Trials Annual Meeting, London 6 July 2006

Whats new and emerging in 2006 in cancer medicine?
Masterclass in Advanced Cancer Medicine: Upper GI Cancer, London, 14 December 2006

If I had £1 million per year of new funding for my network, I would spend it on...
Cancer Agenda for 2005, New Hall, Sutton Coldfield, West Midlands, 4 February 2005

Gastrointestinal stromal tumours
Royal College of Radiologists Annual Meeting, London, 13 September 2005

The Role of the oncologist in managing rectal cancer
Royal Society of Medicine (Coloproctology Section), Leeds, 2 December 2005

Debate: This house believes that patients are entitled to receive cancer treatment of their choice on the NHS
Cancer Focus Seminars: Rare Cancers Training Day, 27 April 2004

What’s new in the non-surgical management of rectal cancer
Association of Coloproctology of Great Britain & Ireland Annual Meeting, Birmingham, 29 June 2004

Neoadjuvant treatment of oesophageal cancer: patient selection, evaluation of response & results
14th World Congress of the International Association of Surgeons & Gastroenterologists (IASG), 9-12 September 2004

Debate: This house believes that patients are entitled to receive cancer treatment of their choice on the NHS
British Oncology Pharmacists’ Association (BOPA) Annual Meeting, Birmingham, 9 October 2004

Controversies in cancer care: upper GI cancer
British Oncological Association Annual Meeting, Manchester, 12 September 2003

NHS Cancer Plan: is it making a difference (debate: opposer)?
Professional & Legal Issues in Cancer Nursing, Walsall, 24 April 2002

Chemoradiotherapy - is there evidence of a radiation dose response?
Chemoradiation: From the Laboratory to the Clinic, Joint Leeds/Royal College of Radiologists Conference, York, 23 November 2000

Preoperative chemoradiotherapy for esophageal cancer: evidence of dose response.
American Society of Clinical Oncology Annual Meeting (poster discussion session), New Orleans, May 2000

Preoperative chemoradiotherapy in oesophageal cancer: is there a dose response?
Combined Chemotherapy & Radiotherapy in GI Tumours, British Institute of Radiology, London, 8 October 1999

Preoperative chemoradiotherapy for locally advanced rectal cancer.
British Oncological Association Annual Meeting (Young Investigator Award), Nottingham, 7 July 1998
 

 

Search Symptoms
and Conditions
What our patients think...
Being a very inexperienced patient as myself it truly helps when staff are considerate in their approach. I found it a very relaxing and informative environment that you and your staff provided me with during my time in your care. ”
Peter Eriksson, Head Coach- Paralympic, UK Athletics Ltd. June 2011